Clinical Trials Sponsored by International Biophysics Corporation

Total 106 results

International Biophysics Corporation

Completed

Effect of HFCWO Vests on Spirometry Measurements

Bronchiectasis | Cystic Fibrosis

United States
International Biophysics Corporation

Completed

Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements

Bronchiectasis | Cystic Fibrosis

United States
Icahn School of Medicine at Mount Sinai
International Biophysics Corporation; SPARK Healthcare

Terminated

Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic

Covid19 | Chronic Obstructive Pulmonary Disease | Chronic Cough

United States
Roll International Corporation

Unknown

Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer

Prostate Cancer

United States
Roll International Corporation

Unknown

Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Prostate Cancer

United States
JN-International Medical Corporation

Completed

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Meningococcal Infections | Meningococcal Meningitis

United States
JN-International Medical Corporation

Completed

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Meningococcal Infections | Meningococcal Meningitis

United States
JN-International Medical Corporation

Completed

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Meningococcal Infections | Meningococcal Meningitis

United States
Pulmonx International Sàrl

Terminated

Long Term Follow up Investigation of Endobronchial Valves in Emphysema (LIVE)

Pulmonary Emphysema

Germany
Radiant Research
Roll International Corporation

Completed

The Effects of Consumption of Pomegranate Juice on Carotid Intima-Media Thickness

Coronary Artery Disease
Seikagaku Corporation
Chiltern International Inc.

Completed

SI-613 Study for Knee Osteoarthritis

Osteoarthritis, Knee

United States
Pulmonx International Sàrl

Completed

Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study (IMPACT)

COPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial Valve

Germany, Austria, Netherlands
Celgene Corporation
Prologue Research International

Completed

Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
Incyte Biosciences International Sàrl

Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

Advanced Malignancies

United States
Incyte Biosciences International Sàrl

Terminated

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Metastatic Cancer | Advanced Malignancies

United States
Boston Scientific Corporation
BTG International Inc.

Completed

TheraSphere for the Treatment of Liver Metastases

Neoplasm Metastasis | Colorectal Cancer | Carcinoma, Neuroendocrine

United States
Incyte Biosciences International Sàrl

Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Cervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditions

United States
Helix BioPharma Corporation
Pharm-Olam International

Completed

A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47

Non-Small Cell Lung Cancer

Poland
Incyte Biosciences International Sàrl

Withdrawn

A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"

BCR-ABL Positive Acute Lymphoblastic Leukemia

Germany, France, Czechia
Celgene Corporation
Prologue Research International

Terminated

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Boston Scientific Corporation
BTG International Inc.

Completed

An International Pulmonary Embolism Registry Using EKOS (KNOCOUT PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom, Switzerland, Austria, France, Germany, Netherlands, Turkey
Hamad Medical Corporation
Laboratoires Besins International

Unknown

Oestrogen Treatment for COVID-19 Symptoms

COVID-19

Qatar
Boston Scientific Corporation
BTG International Inc.

Completed

Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)

Varicose Veins

United States
Incyte Biosciences International Sàrl

Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States
Mondelēz International, Inc.
Cognitive Research Corporation

Completed

Evaluating the Effects of Food Products on Energy and Performance

Energy

United States
Viacor
Duke University; Medifacts International Corporation

Suspended

Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients (PTOLEMY-2)

Heart Failure | Mitral Regurgitation

Belgium, Czech Republic, Germany, Netherlands, Switzerland
Celgene Corporation
Prologue Research International

Completed

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Celgene Corporation
Prologue Research International

Terminated

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.

Prostate Cancer

United States
Incyte Biosciences International Sàrl

Recruiting

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

United States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
Incyte Biosciences International Sàrl

Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Lymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid Leukemia

Spain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
Incyte Biosciences International Sàrl

Withdrawn

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma | Advanced Malignancies | Metastatic Head and Neck Squamous Cell Carcinoma

United States
Incyte Biosciences International Sàrl

Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Metastatic Cancer | Advanced Malignancies

United States, Belgium, Australia, Spain
Incyte Biosciences International Sàrl

Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

Metastatic Cancer | Advanced Malignancies

United States, United Kingdom, Spain, Switzerland
Celgene Corporation
Prologue Research International

Completed

Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)

Non-Hodgkins Lymphoma

United States
Celgene Corporation
Prologue Research International

Completed

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma

United States, Canada
Viacor
Duke University; Medifacts International Corporation

Suspended

Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure (PTOLEMY2Canada)

Heart Failure | Mitral Regurgitation

Canada
Celgene Corporation
Prologue Research International

Completed

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

United States, Canada
Celgene Corporation
Prologue Research International

Terminated

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Ovarian Cancer

United States
Celgene Corporation
Prologue Research International

Terminated

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
MD Anderson International Spain SA
Celgene Corporation

Completed

Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia (LLC-LENAR-08)

Chronic Lymphocytic Leukemia

Spain
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Localized Alveolar Ridge Augmentation With Dental Implant (RidgeDI)

Alveolar Bone Loss

United States
International AIDS Vaccine Initiative
Targeted Genetics Corporation

Completed

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid (TGC14F)

HIV Infections | Human Immunodeficiency Virus Infections

Uganda, South Africa, Zambia
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Sinus Augmentation With Dental Implant (SinusDI)

Maxillary Sinus Bone Loss

United States
Medtronic Spinal and Biologics
Averion International Corporation

Terminated

Localized Alveolar Ridge Augmentation With Space Maintenance Devices (Ridge Mesh)

Alveolar Bone Loss

United States
Roll International Corporation
National Cancer Institute (NCI)

Completed

Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

Prostate Cancer
National Taiwan University Hospital
TCM Biotech International Corporation

Recruiting

Radiation Cystitis Treated With Pentosan Polysulfate Sodium Trial

Radiation Cystitis

Taiwan
CeQur Corporation
International Diabetes Center at Park Nicollet

Completed

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Austria
Air Liquide Santé International
Orion Corporation, Orion Pharma

Completed

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Coronary Artery Disease | Coronary Artery Bypass Graft Surgery | General Anesthetic Drug Allergy

France, Italy, Germany, Netherlands
Janssen-Cilag International NV
Alza Corporation, DE, USA

Completed

A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously (EuroTrans)

Pain | Pain, Postoperative | Analgesia, Patient-Controlled

France, United Kingdom, Germany, Spain, Switzerland, Sweden, Belgium, Austria, Denmark, Ireland
Olympus Corporation of the Americas
International Urogynecology Associates

Completed

Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair

Pelvic Organ Prolapse | Cystocele

United States

Clinical Trials Sponsored by International Biophysics Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations